Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes

Athena Philis‐Tsimikas; Liana K. Billings; Robert Busch; Cristobal Morales Portillo; Rakesh Sahay; Natalie Halladin; Sarah Eggert; Kamilla Begtrup; Stewart Harris

doi:10.1111/dom.13666

Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.13666 ◽

2019 ◽

Vol 21 (6) ◽

pp. 1399-1408 ◽

Cited By ~ 19

Author(s):

Athena Philis‐Tsimikas ◽

Liana K. Billings ◽

Robert Busch ◽

Cristobal Morales Portillo ◽

Rakesh Sahay ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Insulin Degludec ◽

Inhibitor Therapy ◽

Superior Efficacy

Download Full-text

Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial

Diabetes Care ◽

10.2337/dc19-2452 ◽

2020 ◽

Vol 43 (6) ◽

pp. 1249-1257

Author(s):

Hirotaka Watada ◽

Akane Takami ◽

Robert Spranger ◽

Atsushi Amano ◽

Yasuhiro Hashimoto ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5

Diabetes Care ◽

10.2337/dc15-1531 ◽

2015 ◽

Vol 39 (1) ◽

pp. 92-100 ◽

Cited By ~ 52

Author(s):

John B. Buse ◽

Helena W. Rodbard ◽

Carlos Trescoli Serrano ◽

Junxiang Luo ◽

Tibor Ivanyi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Basal Insulin ◽

Previously Treated

Download Full-text

Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2015.09.015 ◽

2015 ◽

Vol 110 (2) ◽

pp. 158-165 ◽

Cited By ~ 10

Author(s):

María S. Ruiz de Adana ◽

Natalia Colomo ◽

Cristina Maldonado-Araque ◽

María I. Fontalba ◽

Francisca Linares ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Respiratory Disease ◽

Basal Insulin ◽

Glucose Monitoring ◽

Efficacy And Safety ◽

Nph Insulin

Download Full-text

Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13574 ◽

2019 ◽

Vol 21 (4) ◽

pp. 781-790 ◽

Cited By ~ 8

Author(s):

Ronan Roussel ◽

Santiago Duran‐García ◽

Yilong Zhang ◽

Suneri Shah ◽

Carolyn Darmiento ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Double Blind ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial

Diabetes Therapy ◽

10.1007/s13300-016-0218-3 ◽

2016 ◽

Vol 8 (1) ◽

pp. 101-114 ◽

Cited By ~ 55

Author(s):

Sultan Linjawi ◽

Bruce W. Bode ◽

Louis B. Chaykin ◽

Jean-Pierre Courrèges ◽

Yehuda Handelsman ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Receptor Agonist ◽

Oral Therapy ◽

Insulin Degludec

Download Full-text

Superior Efficacy of Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) as Add-On to Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) ± Oral Antidiabetic Drug (OAD) Therapy in Patients with Type 2 Diabetes (T2D)—DUAL IX Trial

Diabetes ◽

10.2337/db18-127-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 127-OR ◽

Cited By ~ 3

Author(s):

ATHENA PHILIS-TSIMIKAS ◽

LIANA BILLINGS ◽

ROBERT S. BUSCH ◽

CRISTOBAL MORALES PORTILLO ◽

RAKESH SAHAY ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec ◽

Antidiabetic Drug ◽

Oral Antidiabetic Drug ◽

Oral Antidiabetic ◽

Superior Efficacy ◽

Sodium Glucose Cotransporter

Download Full-text

A pragmatic randomized clinical trial of insulin glargine 300 U/ mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

Diabetes Obesity and Metabolism ◽

10.1111/dom.14152 ◽

2020 ◽

Vol 22 (11) ◽

pp. 2004-2012

Author(s):

Luigi F. Meneghini ◽

Sean D. Sullivan ◽

Gerry Oster ◽

Robert Busch ◽

Anna M. G. Cali ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Basal Insulin ◽

First Generation ◽

Insulin Analogues ◽

Control Study

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Diabetes ◽

10.2337/db18-1057-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1057-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Detemir ◽

Insulin Degludec ◽

Subgroup Analyses

Download Full-text

Faculty Opinions recommendation of Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1147087.604210 ◽

2009 ◽

Author(s):

Suzanne C Ho ◽

Zhaomin Liu

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Soy Protein ◽

Protein Intake ◽

C Reactive Protein ◽

Reactive Protein

Download Full-text

Faculty Opinions recommendation of Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736875953.793568166 ◽

2019 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Vitamin D ◽

Fatty Acid ◽

Randomized Clinical Trial ◽

Kidney Function ◽

Omega 3 ◽

Fatty Acid Supplementation ◽

Omega 3 Fatty Acid

Download Full-text